Trial · NCT00736099
Outcomes46
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 46
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Frequency of Patients With Adverse Events (AEs) | 78 weeks | Treated Set: all screened patients who were documented to have taken at lease 1 dose of study drug. | Participants | NUMBER |
| PRIMARY | Frequency of Patients With Investigator-defined Hypoglycaemic Adverse Events | 78 weeks | Treated Set: all screened patients who were documented to have taken at lease 1 dose of study drug. | Participants | NUMBER |
| PRIMARY | Frequency of Patients With Significant Adverse Events Based on Standardised MedDRA Query (SMQ) | 78 weeks | Treated Set: all screened patients who were documented to have taken at lease 1 dose of study drug. | Participants | NUMBER |
| PRIMARY | Frequency of Patients With Adjudication of Cardiac and Cerebrovascular Events | 78 weeks | Treated Set: all screened patients who were documented to have taken at least 1 dose of study drug | participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Vital Signs | 78 weeks | Treated Set: all screened patients who were documented to have taken at lease 1 dose of study drug. | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Haematology: Eosinophils | 78 weeks | Treated Set with values for Eosinophils | participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Haematology: Haemoglobin | 78 weeks | Treated Set with values for Haemoglobin | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Haematology: Haematocrit | 78 weeks | Treated Set with values for Haematocrit | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Haematology: Red Blood Cell Count | 78 weeks | Treated Set with values for Red blood cell count | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Haematology: White Blood Cell Count | 78 weeks | Treated Set with values for White blood cell count | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Haematology: Platelets | 78 weeks | Treated Set with values for Platelets | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Potassium | 78 weeks | Treated Set with values for Potassium | participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Uric Acid | 78 weeks | Treated Set with values for Uric acid | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Triglycerides | 78 weeks | Treated Set with values for Triglycerides | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Amylase | 78 weeks | Treated Set with values for Amylase | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: γ-Glutamyl-transferase (GGT) | 78 weeks | Treated Set with values for GGT | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Creatinine | 78 weeks | Treated Set with values for Creatinine | Participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Creatinine Kinase | 78 weeks | Treated Set with values for Creatinine kinase | participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Phosphate | 78 weeks | Treated Set with values for Phosphate | participants | NUMBER |
| PRIMARY | Number of Patients With Abnormalities in Clinical Chemistry: Calcium | 78 weeks | Treated Set with values for Calcium | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00736099/outcomes